Macquarie Maintains Outperform on Imax, Raises Price Target to $26
Portfolio Pulse from Benzinga Newsdesk
Macquarie analyst Chad Beynon maintains an Outperform rating on Imax (NYSE:IMAX) and raises the price target from $24 to $26.
July 26, 2024 | 1:27 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Macquarie analyst Chad Beynon maintains an Outperform rating on Imax and raises the price target from $24 to $26.
The Outperform rating and increased price target from a reputable analyst at Macquarie is likely to boost investor confidence in Imax, potentially driving the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100